OrbiMed Capital GP VI LLC - Insider Non-Derivative Transactions at Prelude Therapeutics Inc (PRLD) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 22, 2023, OrbiMed Capital GP VI LLC's relationship to Prelude Therapeutics Inc (PRLD) is Director,TenPercentOwner, and currently has 10,119,756 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PRLD insiders.
Data Source: SEC.
OrbiMed Capital GP VI LLC - Insider Non-Derivative Transactions at PRLD
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 23, 2023 | P -- (Common Stock) | 869565 | 5.75 | 10119756 |